Skip to content
Search

Latest Stories

Half a million more at risk of type 2 diabetes in England in one year

Half a million more at risk of type 2 diabetes in England in one year

There was an almost 25 per cent increase in the number of individuals under the age of 40 at risk of type 2 diabetes

The number of people in England identified as at risk for type 2 diabetes mellitus (T2DM) has increased by over half a million within a year, according to NHS figures.


Data released by the National Diabetes Audit on June 12 showed that 3.6 million people registered with a GP were found to have non-diabetic hyperglycaemia (also known as pre-diabetes) in 2023, compared with 3.1 million people in 2022 — a notable 18 per cent increase or nearly 550,000 people.

Among those under 40 years old, the figures showed an increase of almost 25 per cent from 173,166 in 2022 to 216,440 in 2023.

People with non-diabetic hyperglycaemia have higher-than-normal blood sugar levels, and they are at greater risk for developing type 2 diabetes and cardiovascular diseases. Typically, this condition is detected through routine blood tests at GP surgeries.

Amanda Pritchard, NHS chief executive, expressed deep concern over the figures, emphasising that type 2 diabetes is not only linked to kidney failure, amputation, heart attack, stroke, and many of the common types of cancer, but it also adds pressure to NHS services.

She assured that the NHS will continue to develop services that support people at risk of developing type 2 diabetes to lead healthier lives.

The NHS has introduced a range of innovative services to prevent people from developing type 2 diabetes and to reduce obesity rates, including the world-leading Healthier You NHS Diabetes Prevention Programme.

More than 1.6 million people have been offered support through the nine-month programme, which provides personalised support with practical tools and advice on healthy eating and lifestyle, increasing physical activity and weight management.

Dr. Clare Hambling, National Clinical Director of Diabetes and Obesity at NHS England, highlighted that the prevalence of type 2 diabetes among individuals under 40 is increasing worldwide, including in England.

According to the NHS, around nine out of 10 people in England living with diabetes have type 2.

The NHS England-funded Type 2 Diabetes and the Young (T2DAY) initiative ensures that people living with early-onset type 2 diabetes receive all recommended diabetes health checks, personalised support tailored to their needs, and evidence-based management to stay well and avoid complications.

It includes additional clinical reviews for those aged 18 to 39 years old living with type 2 diabetes.

The ambitious programme, now entering its second year, is believed to be the world-first targeted support for these high-risk people living with diabetes.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less